Adult acute erythroleukemia: An analysis of 91 patients treated at a single institution

F. P.S. Santos, S. Faderl, G. Garcia-Manero, C. Koller, M. Beran, S. O'Brien, S. Pierce, E. J. Freireich, X. Huang, G. Borthakur, C. Bueso-Ramos, M. De Lima, M. Keating, J. Cortes, H. Kantarjian, F. Ravandi

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


Acute erythroleukemia (AML-M6) is an uncommon subtype of acute myeloid leukemia (AML); it is considered to have a poor prognosis. From 1 January 1980 to 21 May 2008, 91 patients with newly diagnosed AML-M6 were seen at the University of Texas-M.D. Anderson Cancer Center (UT-MDACC). Forty-five patients (50%) had a history of myelodysplatic syndrome (MDS), compared with 41% in our control group (patients with other AML subtypes) (P=0.08). Poor-risk cytogenetics were more common in patients with AML-M6 (61% versus 38%, P=0.001). Complete remission rates were 62% for patients with AML-M6, comparing with 58% for the control group (P=0.35). Median disease free survival (DFS) for patients with AML-M6 was 32 weeks, versus 49 weeks for the control group (P=0.05). Median overall survival (OS) of patients with AML-M6 was 36 weeks, compared with 43 weeks for the control group (P=0.60). On multivariate analysis for DFS and OS, AML-M6 was not an independent risk factor. AML-M6 is commonly associated with a previous diagnosis of MDS and poor-risk karyotype. The diagnosis of AML-M6 does not impart by itself a worse prognosis, and treatment decisions on this disease should be guided by well known AML prognostic factors.

Original languageEnglish (US)
Pages (from-to)2275-2280
Number of pages6
Issue number12
StatePublished - Dec 2009
Externally publishedYes


  • acute erythroleukemia
  • clinical features
  • prognosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'Adult acute erythroleukemia: An analysis of 91 patients treated at a single institution'. Together they form a unique fingerprint.

Cite this